CD55-targeting vaccine (Viragen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD55-targeting vaccine (Viragen)
Drug Alias NameCD55-targeting vaccine (University of Nottingham)CD55-targeting vaccine (Cancer Research UK)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionComplement decay-accelerating factor modulators
TargetsComplement decay-accelerating factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViragenUniversity Of NottinghamCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A